# EDGAR Filing Document

**Accession Number:** 0000862692
**File Stem:** 0001209191-23-002380
**Filing Date:** 2023-1
**Character Count:** 8265
**Document Hash:** 87b50934729ddc585c72cabd94f3be17
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001209191-23-002380.hdr.sgml**: 20230106

**ACCESSION NUMBER**: 0001209191-23-002380

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20221223

**FILED AS OF DATE**: 20230106

**DATE AS OF CHANGE**: 20230106

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** PORTNOY DAVID
- **CENTRAL INDEX KEY:** 0001315416

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40767
- **FILM NUMBER:** 23515756

**MAIL ADDRESS:**
- **STREET 1:** C/O FOCUS FINANCIAL GROUP
- **STREET 2:** 61 HARBOUR WAY
- **CITY:** BAL HARBOUR
- **STATE:** FL
- **ZIP:** 33154
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CRYO CELL INTERNATIONAL INC
- **CENTRAL INDEX KEY:** 0000862692
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **IRS NUMBER:** 223023093
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1130

**BUSINESS ADDRESS:**
- **STREET 1:** 700 BROOKER CREEK BLVD
- **STREET 2:** SUITE 1800
- **CITY:** OLDSMAR
- **STATE:** FL
- **ZIP:** 34677
- **BUSINESS PHONE:** 813-749-2104

**MAIL ADDRESS:**
- **STREET 1:** 700 BROOKER CREEK BLVD
- **STREET 2:** SUITE 1800
- **CITY:** OLDSMAR
- **STATE:** FL
- **ZIP:** 34677

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>PORTNOY DAVID<br><sub>(Last) (First) (Middle)</sub><br>700 BROOKER CREEK BLVD<br>SUITE 1800<br><sub>(Street)</sub><br>OLDSMAR, FL 34677<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2022-12-23 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chairman, Co-CEO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>CRYO CELL INTERNATIONAL INC [ CCEL ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock |  |  |  |  |  |  |  | 804742 | D |  |
| Common Stock |  |  |  |  |  |  |  | 117012 | I | By 401K |
| Common Stock |  |  |  |  |  |  |  | 230621 | I | By IRA |
| Common Stock |  |  |  |  |  |  |  | 102586 | I | By Spouse |
| Common Stock |  |  |  |  |  |  |  | 152882 | I | By Corporation<sup>(1)</sup> |
| Common Stock |  |  |  |  |  |  |  | 15611 | I | as Custodian for Daughter |
| Common Stock |  |  |  |  |  |  |  | 59027 | I | By LLC |
| Common Stock |  |  |  |  |  |  |  | 55219 | I | By Corporation<sup>(2)</sup> |
| Common Stock |  |  |  |  |  |  |  | 11352 | I | As Custodian for Son |
| Common Stock |  |  |  |  |  |  |  | 11242 | I | As Custodian for Son |
| Common Stock |  |  |  |  |  |  |  | 10783 | I | As Custodian for Son |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Option | $7.92 |  |  |  |  |  |  | 2018-03-08 | 2023-03-08 | Common Stock | 23636 |  | 23636 | D |  |
| Stock Option | $7.53 |  |  |  |  |  |  | 2019-08-30 | 2029-08-30 | Common Stock | 26243 |  | 26243 | D |  |
| Stock Option | $7.28 |  |  |  |  |  |  | 2019-12-20 | 2029-12-20 | Common Stock | 23636 |  | 23636 | D |  |
| Stock Option | $12.27 |  |  |  |  |  |  | 2021-12-22<sup>(3)</sup> | 2024-12-22 | Common Stock | 553 |  | 553 | D |  |
| Stock Option | $12.27 |  |  |  |  |  |  | 2021-12-22<sup>(4)</sup> | 2028-12-22 | Common Stock | 280000 |  | 280000 | D |  |
| Stock Option | $13.50 |  |  |  |  |  |  | 2021-12-22<sup>(3)</sup> | 2024-12-22 | Common Stock | 24447 |  | 24447 | D |  |
| Stock Option | $4.77 |  |  |  |  |  |  | 2023-01-03<sup>(5)</sup> | 2028-01-03 | Common Stock | 50000 |  | 50000 | D |  |
| Stock Option | $4.30 | 2022-12-23 |  | A |  | 50000 |  | 2022-12-23<sup>(6)</sup> | 2027-12-23 | Common Stock | 50000 | $4.30 | 50000 | D |  |

---

### Footnotes:

(1) Shares of Common Stock held by Mayim Investment Limited Partnership as is David I. Portnoy my be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership.

(2) Shares of Common Stock held by uTIPu, Inc., as to which David I. Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary.

(3) One-third of the stock options will vest on December 22, 2022, one-third will vest on December 22, 2023 and one-third on December 22, 2024.

(4) Stock options vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term.

(5) 8,750 options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026.

(6) Pursuant to the executive's Employment Agreement effective December 1, 2022, stock options will be awarded and will vest immediately if the price of the Company's stock reaches $8.00 per share during the five-year option term.

**Signature:** /s/ David Portnoy  
**Date:** 2023-01-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**